首页|Advances in the treatment of IgA nephropathy with biological agents

Advances in the treatment of IgA nephropathy with biological agents

扫码查看

anti-CD20 monoclonal antibodiesAPRILbiological agentsBLyScomplementIgA nephropathy

Zhuang Yongze、Lu Hailing、Li Junxia

展开 >

Department of Nephrology, 900 Hospital of the Joint Logistics Team, PLA, Fuzhou General Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China

anti-CD20 monoclonal antibodies APRIL biological agents BLyS complement IgA nephropathy

Key Clinical Specialty Discipline Construction Program of FujianFujian Clinical Medical Research Center for Immune Kidney Disease

2017ZDZKSB2021Y2016

2024

慢性疾病与转化医学(英文)

慢性疾病与转化医学(英文)

CSTPCD
ISSN:2095-882X
年,卷(期):2024.10(1)
  • 41